Cargando...
NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma
Background: Novel immune therapies targeting tumor specific antigens are being developed. Our purpose was to determine expression of the cancer testes antigen NY-ESO-1 in renal cell carcinoma (RCC), as NY-ESO-1 targeting approaches, particularly adoptive cell therapy, have not been evaluated in this...
Gardado en:
Main Authors: | , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado: |
Impact Journals LLC
2014
|
Assuntos: | |
Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4170640/ https://ncbi.nlm.nih.gov/pubmed/24970819 |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|